Bioasis Technologies Inc. V.BTI

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

TSXV:BTI - Post by User

Bioasis Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by AlfredSisleyon Mar 11, 2021 5:32pm

176 Views

Post# 32781599

DENALI - FAST TRACK DESIGNATION (MPS II)

https://www.globenewswire.com/news-release/2021/03/11/2191402/0/en/Denali-Therapeutics-Announces-Fast-Track-Designation-Granted-by-the-U-S-FDA-to-ETV-IDS-DNL310-for-the-Treatment-of-Patients-with-Hunter-Syndrome-MPS-II.html

<< Previous

Bullboard Posts

Next >>

Infield Minerals to acquire Kings Canyon Gold Property